#MyeloidLeukemia
LightNews LightNews
thecancersurvivorsclub.com
Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure! #TCSC #cml #myeloid #leukemia #leukaemia #myeloidleukemia #bloodcancer

www.mskcc.org/news/newly-a...
Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure
MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.
www.mskcc.org
January 18, 2025 at 7:57 AM
oncologynurseadv.bsky.social
Adding enasidenib to venetoclax appears to be safe and effective in IDH2-mutated, R/R acute #myeloidLeukemia. Published in @thelancethaem.bsky.social and @hematologyadvisor.bsky.social.

https://bit.ly/49zsjy9

#AML #leusm
Enasidenib Is a Safe and Effective Intervention in IDH2-Mutated AML and MDS - Oncology Nurse Advisor
Researchers sought to determine whether combining enasidenib with venetoclax would be effective in patients with IDH2-mutated, relapsed or refractory AML.
bit.ly
January 18, 2026 at 6:38 PM
einsteinmededu.bsky.social
Einstein Research: Promising New Therapy for Acute Myeloid Leukemia

Read more at bit.ly/441ro8k.

#MedSky #leukemia #myeloidleukemia
Promising New Therapy for Acute Myeloid Leukemia
bit.ly
April 2, 2025 at 8:28 PM
yleyfman.bsky.social
#Leukemia, #CML, #BloodCancer, #CancerAwareness, #LeukemiaAwareness, #ChronicMyeloidLeukemia, #Hematology, #Oncology, #BloodDisorders, #CancerResearch, #LeukemiaSupport, #CancerTreatment, #MyeloidLeukemia, #LeukemiaPatients, #BloodCancerAwareness, #CancerFight, #LeukemiaJourney, #CancerSurvivor,
March 6, 2025 at 3:30 AM